AEON Biopharma (AEON) Cash & Equivalents (2021 - 2026)
AEON Biopharma (AEON) reported Cash & Equivalents of $3.43 million for Q2 2026, down 59.3% from $8.44 million a year earlier.
Powered by 
Analysis
AEON Biopharma (AEON) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, AEON Biopharma posted Cash & Equivalents of $3.01 million.
- Cash & Equivalents has a four-year compound annual growth rate of 56.8% (FY2021 to FY2025).
- By year, Cash & Equivalents came in at $13,000 in FY2024 (-99.7%), $5.16 million in FY2023 (-47.1%), $9.75 million in FY2022 and $497,412 in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $7,758 in Q2 2022 and a high of $10.45 million in Q1 2025.
- Year over year, Cash & Equivalents gained in two of the last four quarters, with growth averaging 139.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2025 (growth of 570.5%); the low point was Q4 2024 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 976.00 Mn |
| 10 | AEON Biopharma | 11.93 Mn | -8.87 Mn | - | 3.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.43 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 8.44 Mn |
| Mar 31, 2025 | 10.45 Mn |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 537,000.00 |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | 441,377.00 |
| Mar 31, 2023 | 457,085.00 |
| Dec 31, 2022 | 9.75 Mn |
| Sep 30, 2022 | 27,759.00 |
| Jun 30, 2022 | 7,758.00 |
| Mar 31, 2022 | 166,243.00 |
| Dec 31, 2021 | 497,412.00 |
| Sep 30, 2021 | 663,540.00 |
| Jun 30, 2021 | 988,855.00 |
API Access
AEON Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AEON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AEON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AEON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();